Watson-Marlow Fluid Technology Group Acquires Aflex Hose
WMFTG acquired Aflex Hose adding polytetrafluoroethylene-lined flexible hoses to its fluid path product portfolio.
On Dec. 1, 2016 Watson-Marlow Fluid Technology Group (WMFTG) announced that it has acquired Aflex Hose Limited and its subsidiary Aflex Hose USA through its parent company Spirax-Sarco Engineering plc, for £61.4 million (approximately $77.65 USD). Aflex is based in Halifax, England and has a sales/assembly operation in PA. The company specializes in the design and manufacture of polytetrafluoroethylene-lined flexible hoses for the pharmaceutical, food, and chemical process industries. Aflex adds to WMFTG’s fluid path product portfolio and joins a range of products including Watson-Marlow pumps, Watson-Marlow tubing, Flexicon filling systems, BioPure single-use tubing connector systems, Asepco aseptic valves, FlowSmart seals and gaskets, Alitea OEM Pumps, MasoSine process pumps, and Bredel hose pumps.
Source: Watson-Marlow Fluid Technology Group
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
